Name | Diversicare Of Boaz |
---|---|
Location | 600 Corley Avenue, Boaz, Alabama |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 100 |
Occupancy Rate | 93.6% |
Medicare ID (CCN) | 015063 |
Legal Business Name | Diversicare Of Boaz Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1396290466 |
Organization Name | DIVERSICARE OF BOAZ, LLC |
Doing Business As | DIVERSICARE OF BOAZ |
Address | 600 Corley Ave, Boaz, AL 35957 |
Phone Number | 256-593-8380 |
News Archive
iCONECT, developers of the award winning, visually rich and intuitively simple XERA e-discovery software, announced today that it is establishing a partnership with Lockheed Martin's Information Systems & Global Solutions to address application decommissioning needs in the U.S. commercial healthcare industry, consolidate silos of legacy electronic medical records (EMR), and reduce the cost of preserving and accessing these records.
Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results in periodic flu-like symptoms and severe fever. Severe cases of the disease are accompanied by tissue damage and result in potentially fatal organ failure.
A University of Maryland-led research team has been awarded a three-year $1.7 million grant from the National Institutes of Health (NIH) to develop new imaging technologies and data analysis techniques that will further our understanding of how large networks of neurons in the brain interact to process sensory information.
Patients with non-small cell lung cancer (NSCLC) often respond to standard chemotherapy, only to develop drug resistance later, and with fatal consequences.
Millions of individuals worldwide are exposed to shift work and numerous environmental conditions that disturb circadian clock function and disrupt normal circadian rhythms. Environmental conditions associated with disrupted circadian rhythms greatly increase the risk for development of type 2 diabetes and metabolic syndrome and also hinder the treatment and management of hyperglycemia in existing patients with diabetes.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
iCONECT, developers of the award winning, visually rich and intuitively simple XERA e-discovery software, announced today that it is establishing a partnership with Lockheed Martin's Information Systems & Global Solutions to address application decommissioning needs in the U.S. commercial healthcare industry, consolidate silos of legacy electronic medical records (EMR), and reduce the cost of preserving and accessing these records.
Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results in periodic flu-like symptoms and severe fever. Severe cases of the disease are accompanied by tissue damage and result in potentially fatal organ failure.
A University of Maryland-led research team has been awarded a three-year $1.7 million grant from the National Institutes of Health (NIH) to develop new imaging technologies and data analysis techniques that will further our understanding of how large networks of neurons in the brain interact to process sensory information.
Patients with non-small cell lung cancer (NSCLC) often respond to standard chemotherapy, only to develop drug resistance later, and with fatal consequences.
Millions of individuals worldwide are exposed to shift work and numerous environmental conditions that disturb circadian clock function and disrupt normal circadian rhythms. Environmental conditions associated with disrupted circadian rhythms greatly increase the risk for development of type 2 diabetes and metabolic syndrome and also hinder the treatment and management of hyperglycemia in existing patients with diabetes.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $3250 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 6.56 | 14.46 |
Percentage of long-stay residents who lose too much weight | 3.07 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 39.23 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.42 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.74 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 5.56 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 21.24 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.18 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.42 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 11.3 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 26.14 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 2.92 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.71 | 95.98 |
Percentage of short-stay residents who made improvements in function | 83.45 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.92 | 82.93 |
News Archive
iCONECT, developers of the award winning, visually rich and intuitively simple XERA e-discovery software, announced today that it is establishing a partnership with Lockheed Martin's Information Systems & Global Solutions to address application decommissioning needs in the U.S. commercial healthcare industry, consolidate silos of legacy electronic medical records (EMR), and reduce the cost of preserving and accessing these records.
Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results in periodic flu-like symptoms and severe fever. Severe cases of the disease are accompanied by tissue damage and result in potentially fatal organ failure.
A University of Maryland-led research team has been awarded a three-year $1.7 million grant from the National Institutes of Health (NIH) to develop new imaging technologies and data analysis techniques that will further our understanding of how large networks of neurons in the brain interact to process sensory information.
Patients with non-small cell lung cancer (NSCLC) often respond to standard chemotherapy, only to develop drug resistance later, and with fatal consequences.
Millions of individuals worldwide are exposed to shift work and numerous environmental conditions that disturb circadian clock function and disrupt normal circadian rhythms. Environmental conditions associated with disrupted circadian rhythms greatly increase the risk for development of type 2 diabetes and metabolic syndrome and also hinder the treatment and management of hyperglycemia in existing patients with diabetes.
› Verified 4 days ago